Physician profile
Eva Prieto
NPI 1487207775
$1,244.23
in general payments reported to CMS, 2019-2025
12 companies · $718 in 2025
The $718 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $33.39 · 2023: $238 · 2024: $255 · 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $441.64 | 2024-2025 | Airsupra, Datroway, Farxiga |
| Glaxosmithkline, LLC. | $324.66 | 2023-2025 | Arexvy, Shingrix |
| Lilly USA, LLC | $150.59 | 2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $97.80 | 2024-2025 | |
| Exact Sciences Corporation | $71.36 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $43.26 | 2023-2024 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $39.20 | 2022-2023 | Rexulti |
| Idorsia Pharmaceuticals US INC | $16.63 | 2023 | Quviviq |
| Medtronic, INC. | $15.61 | 2025 | Intellis Adaptivestim |
| Corcept Therapeutics | $15.07 | 2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.74 | 2022 | |
| Amgen INC. | $13.67 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Prieto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.